Free Trial

Xometry (XMTR) Financials

Xometry logo
$34.39 -0.54 (-1.55%)
As of 01:34 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Annual Income Statements for Xometry

Annual Income Statements for Xometry

This table shows Xometry's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Net Income / (Loss) Attributable to Common Shareholders
-50 -67 -79 -61 -40 -31
Consolidated Net Income / (Loss)
-50 -67 -79 -61 -31 -31
Net Income / (Loss) Continuing Operations
-50 -67 -79 -61 -31 -31
Total Pre-Tax Income
-50 -68 -79 -61 -31 -31
Total Operating Income
-56 -74 -77 -59 -29 -31
Total Gross Profit
216 178 146 57 33 15
Total Revenue
546 463 381 218 141 80
Operating Revenue
546 463 381 218 141 80
Total Cost of Revenue
330 285 235 161 108 65
Operating Cost of Revenue
330 285 235 161 108 65
Total Operating Expenses
272 252 223 116 63 45
Selling, General & Admin Expense
65 71 58 35 12 8.02
Marketing Expense
108 94 84 39 23 15
Research & Development Expense
39 34 31 18 12 11
Other Operating Expenses / (Income)
59 52 49 24 14 10
Impairment Charge
0.08 0.40 0.82 0.00 1.59 1.72
Total Other Income / (Expense), net
5.73 5.76 -1.92 -2.70 -1.87 -0.45
Interest Expense
4.75 4.78 4.42 0.85 1.09 0.24
Interest & Investment Income
11 12 4.69 1.02 0.00 0.00
Other Income / (Expense), net
-0.76 -1.51 -2.18 -2.87 -0.78 -0.20
Income Tax Expense
-0.02 -0.35 0.04 0.00 0.00 -
Preferred Stock Dividends Declared
0.00 0.00 0.00 0.00 8.80 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.00 0.01 0.02 -0.00 0.00 0.00
Basic Earnings per Share
($2.06) ($2.82) ($3.36) ($4.66) ($5.32) ($4.88)
Weighted Average Basic Shares Outstanding
98.17M 95.83M 94.32M 52.64M 7.49M 6.35M
Diluted Earnings per Share
($2.06) ($2.82) ($3.36) ($4.66) ($5.32) ($4.88)
Weighted Average Diluted Shares Outstanding
98.17M 95.83M 94.32M 52.64M 7.49M 6.35M
Weighted Average Basic & Diluted Shares Outstanding
50.30M 48.58M 45.07M 26.32M 7.49M 6.35M

Quarterly Income Statements for Xometry

This table shows Xometry's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
-15 -9.89 -10 -14 -17 -11 -12 -27 -18 -27 -15
Consolidated Net Income / (Loss)
-15 -9.90 -10 -14 -17 -11 -12 -27 -18 -27 -15
Net Income / (Loss) Continuing Operations
-15 -9.90 -10 -14 -17 -11 -12 -27 -18 -27 -15
Total Pre-Tax Income
-15 -9.94 -10 -14 -17 -11 -12 -27 -18 -27 -15
Total Operating Income
-15 -12 -11 -15 -18 -13 -13 -28 -20 -27 -15
Total Gross Profit
56 59 56 53 48 49 46 44 39 34 41
Total Revenue
151 149 142 133 123 128 119 111 105 98 104
Operating Revenue
151 149 142 133 123 128 119 111 105 98 104
Total Cost of Revenue
95 90 86 80 75 79 73 67 66 64 63
Operating Cost of Revenue
95 90 86 80 75 79 73 67 66 64 63
Total Operating Expenses
72 71 67 68 66 62 59 72 59 62 56
Selling, General & Admin Expense
17 17 16 16 15 14 15 26 16 15 15
Marketing Expense
26 27 27 27 27 25 23 23 22 26 21
Research & Development Expense
11 10 9.34 10 9.59 8.89 8.52 8.92 8.13 8.31 7.61
Other Operating Expenses / (Income)
17 16 15 14 14 13 13 14 13 12 12
Total Other Income / (Expense), net
0.32 1.59 1.31 1.58 1.25 1.43 1.33 1.43 1.58 0.48 0.16
Interest Expense
1.19 1.19 1.19 1.19 1.19 1.19 1.21 1.19 1.20 1.25 1.19
Interest & Investment Income
2.38 2.47 2.94 3.00 2.83 2.97 3.13 3.20 2.76 2.21 1.64
Other Income / (Expense), net
-0.88 0.31 -0.44 -0.23 -0.39 -0.36 -0.60 -0.58 0.02 -0.45 -0.29
Income Tax Expense
0.00 -0.04 0.03 -0.01 0.00 -0.56 0.14 -0.07 0.14 0.60 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 -0.01 0.00 -0.01 0.01 -0.00 0.01 -0.01 0.00 -0.00 -0.00
Basic Earnings per Share
($0.30) ($1.23) ($0.21) ($0.28) ($0.34) ($1.64) ($0.25) ($0.55) ($0.38) ($2.26) ($0.32)
Weighted Average Basic Shares Outstanding
50.34M 98.17M 49.28M 48.84M 48.58M 95.83M 47.99M 47.87M 47.70M 94.32M 47.30M
Diluted Earnings per Share
($0.30) ($1.23) ($0.21) ($0.28) ($0.34) ($1.64) ($0.25) ($0.55) ($0.38) ($2.26) ($0.32)
Weighted Average Diluted Shares Outstanding
50.34M 98.17M 49.28M 48.84M 48.58M 95.83M 47.99M 47.87M 47.70M 94.32M 47.30M
Weighted Average Basic & Diluted Shares Outstanding
50.68M 50.30M 49.56M 49.30M 46.12M 48.58M 45.39M 45.29M 45.17M 45.07M 44.76M

Annual Cash Flow Statements for Xometry

This table details how cash moves in and out of Xometry's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Net Change in Cash & Equivalents
-31 -12 -21 26 20 25
Net Cash From Operating Activities
-15 -30 -63 -69 -22 -27
Net Cash From Continuing Operating Activities
-15 -30 -63 -69 -22 -27
Net Income / (Loss) Continuing Operations
-50 -67 -79 -61 -31 -31
Consolidated Net Income / (Loss)
-50 -67 -79 -61 -31 -31
Depreciation Expense
13 11 7.82 3.60 3.12 1.85
Amortization Expense
1.86 1.86 1.72 0.00 0.00 -0.04
Non-Cash Adjustments To Reconcile Net Income
36 38 33 13 3.95 3.54
Changes in Operating Assets and Liabilities, net
-15 -13 -26 -24 1.97 -1.48
Net Cash From Investing Activities
-20 17 -239 -213 6.67 -2.35
Net Cash From Continuing Investing Activities
-20 17 -239 -213 6.67 -2.35
Purchase of Property, Plant & Equipment
-18 -18 -14 -6.26 -4.19 -2.69
Acquisitions
0.00 -3.35 0.00 -175 0.00 -1.43
Purchase of Investments
-19 -12 -284 -267 -18 -29
Sale of Property, Plant & Equipment
0.08 0.22 0.19 0.00 0.00 0.16
Sale and/or Maturity of Investments
17 50 59 235 29 30
Other Investing Activities, net
0.00 0.00 0.00 0.63 0.00 0.00
Net Cash From Financing Activities
4.64 1.07 281 308 35 55
Net Cash From Continuing Financing Activities
4.64 1.07 281 308 35 55
Repayment of Debt
0.00 0.00 -9.31 -16 -4.78 -0.50
Repurchase of Preferred Equity
0.00 0.00 0.00 0.00 -13 0.00
Repurchase of Common Equity
0.00 0.00 0.00 -3.68 0.00 0.00
Payment of Dividends
0.00 0.00 0.00 0.00 -8.80 0.00
Issuance of Debt
0.00 0.00 288 0.00 8.78 0.00
Issuance of Preferred Equity
0.00 0.00 0.00 0.00 52 55
Issuance of Common Equity
0.00 0.00 0.00 325 0.00 0.00
Other Financing Activities, net
4.64 1.07 2.78 2.32 0.51 0.29
Effect of Exchange Rate Changes
-0.27 -0.23 -0.37 -0.06 -0.13 -
Cash Interest Paid
2.88 2.88 1.41 0.91 1.27 1.11

Quarterly Cash Flow Statements for Xometry

This table details how cash moves in and out of Xometry's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
-6.73 4.80 -4.64 -24 -7.72 9.05 -12 17 -26 35 -16
Net Cash From Operating Activities
-3.69 9.09 -3.63 -9.10 -12 -1.29 -5.98 -6.15 -16 -17 -11
Net Cash From Continuing Operating Activities
-3.66 9.09 -3.63 -9.10 -12 -1.29 -5.81 -6.32 -16 -17 -11
Net Income / (Loss) Continuing Operations
-15 -9.90 -10 -14 -17 -11 -12 -27 -18 -27 -15
Consolidated Net Income / (Loss)
-15 -9.90 -10 -14 -17 -11 -12 -27 -18 -27 -15
Depreciation Expense
4.25 3.39 3.21 3.26 3.15 2.80 2.48 2.90 2.57 2.10 1.91
Amortization Expense
0.47 0.47 0.46 0.47 0.46 0.46 -12 13 0.47 0.47 0.47
Non-Cash Adjustments To Reconcile Net Income
8.87 10 8.44 9.58 7.38 7.42 20 3.96 7.05 10 8.71
Changes in Operating Assets and Liabilities, net
-2.16 5.01 -5.55 -8.70 -6.13 -1.42 -4.31 0.74 -8.20 -2.21 -7.36
Net Cash From Investing Activities
-3.69 -5.45 -2.59 -15 2.93 11 -6.56 23 -10 53 -5.51
Net Cash From Continuing Investing Activities
-3.69 -5.45 -2.59 -15 2.93 11 -6.56 23 -10 53 -5.51
Purchase of Property, Plant & Equipment
-5.50 -4.54 -4.81 -4.40 -4.35 -6.42 -3.57 -4.31 -4.19 -4.04 -4.17
Purchase of Investments
-2.27 -2.50 -2.77 -11 -2.73 -2.95 -2.99 -2.95 -2.69 -2.20 -1.34
Sale and/or Maturity of Investments
4.08 1.59 4.99 0.01 10 20 - 30 0.00 59 -
Net Cash From Financing Activities
0.51 1.42 1.42 0.56 1.23 -0.36 0.28 0.66 0.48 -0.53 0.85
Net Cash From Continuing Financing Activities
0.51 1.42 1.42 0.56 1.23 -0.36 0.28 0.66 0.48 -0.53 0.85
Other Financing Activities, net
0.51 1.42 1.42 0.56 1.23 -0.36 0.28 0.66 0.48 -0.53 0.85
Effect of Exchange Rate Changes
0.14 -0.26 0.17 -0.02 -0.15 0.08 -0.11 -0.22 0.02 0.06 -0.36
Cash Interest Paid
1.44 - 1.44 - 1.44 - 1.44 - 1.44 - 1.41

Annual Balance Sheets for Xometry

This table presents Xometry's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Total Assets
680 707 734 503 89
Total Current Assets
328 356 387 163 78
Cash & Equivalents
22 53 66 86 60
Short-Term Investments
218 215 254 30 0.00
Accounts Receivable
74 70 49 32 15
Inventories, net
3.92 2.89 1.57 2.03 2.29
Prepaid Expenses
4.95 5.57 7.59 6.66 0.91
Other Current Assets
4.87 8.90 9.37 5.58 0.00
Plant, Property, & Equipment, net
45 36 19 10 6.11
Total Noncurrent Assets
308 316 328 329 5.20
Long-Term Investments
4.07 4.11 4.07 4.20 0.00
Goodwill
263 263 258 255 0.83
Intangible Assets
32 36 39 42 1.65
Other Noncurrent Operating Assets
8.87 13 26 28 2.71
Total Liabilities & Shareholders' Equity
680 707 734 503 89
Total Liabilities
365 377 362 77 39
Total Current Liabilities
75 83 64 57 38
Accounts Payable
35 44 12 13 5.64
Accrued Expenses
24 23 33 31 14
Current Deferred & Payable Income Tax Liabilities
0.98 2.48 3.96 0.00 -
Other Current Liabilities
14 14 5.47 5.55 3.38
Total Noncurrent Liabilities
290 294 298 20 1.12
Long-Term Debt
284 282 280 0.00 -
Noncurrent Deferred Revenue
0.00 0.00 0.00 1.45 0.00
Noncurrent Deferred & Payable Income Tax Liabilities
0.23 0.28 0.43 0.02 -
Other Noncurrent Operating Liabilities
5.89 12 18 19 1.12
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
316 330 372 425 -111
Total Preferred & Common Equity
314 329 371 424 -111
Preferred Stock
0.00 0.00 0.00 0.00 0.00
Total Common Equity
314 329 371 424 -111
Common Stock
685 648 623 598 0.50
Retained Earnings
-370 -320 -252 -173 -112
Accumulated Other Comprehensive Income / (Loss)
-0.33 0.86 0.03 0.15 0.21
Noncontrolling Interest
1.14 1.12 1.09 1.03 0.00

Quarterly Balance Sheets for Xometry

This table presents Xometry's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/31/2025 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets
690 678 679 692 701 708 725 754
Total Current Assets
335 326 327 341 357 365 373 410
Cash & Equivalents
16 17 22 46 44 57 40 30
Short-Term Investments
216 217 219 208 232 229 256 311
Accounts Receivable
86 79 71 69 64 58 52 51
Inventories, net
4.03 3.50 2.87 2.89 1.31 1.34 1.44 5.63
Prepaid Expenses
6.49 4.79 6.06 6.00 4.90 5.83 7.06 7.68
Other Current Assets
7.19 4.86 6.51 9.37 10 14 16 4.36
Plant, Property, & Equipment, net
47 42 40 38 26 24 22 16
Total Noncurrent Assets
308 310 312 314 318 320 330 328
Long-Term Investments
4.07 4.21 4.14 4.21 4.21 4.27 4.13 4.30
Goodwill
263 263 263 263 263 263 262 260
Intangible Assets
31 33 34 35 37 38 39 40
Other Noncurrent Operating Assets
9.92 9.98 11 12 14 15 25 24
Total Liabilities & Shareholders' Equity
690 678 679 692 701 708 725 754
Total Liabilities
379 362 362 371 364 366 362 361
Total Current Liabilities
89 71 71 79 68 69 65 65
Accounts Payable
50 6.37 10 14 13 13 12 12
Accrued Expenses
23 49 43 46 35 37 32 36
Current Deferred Revenue
9.91 8.30 9.05 9.61 9.66 10.00 9.97 11
Current Deferred & Payable Income Tax Liabilities
0.89 0.86 1.33 2.21 2.96 2.80 4.11 -
Other Current Liabilities
5.29 6.64 6.66 6.73 6.74 6.50 6.26 5.90
Total Noncurrent Liabilities
290 291 291 292 296 297 298 296
Long-Term Debt
284 283 283 282 281 281 280 279
Noncurrent Deferred & Payable Income Tax Liabilities
0.23 0.25 0.26 0.28 0.36 0.39 0.41 -
Other Noncurrent Operating Liabilities
5.33 7.55 8.17 9.63 14 16 17 15
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
311 316 317 322 337 342 362 393
Total Preferred & Common Equity
310 315 316 320 336 341 361 392
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
310 315 316 320 336 341 361 392
Common Stock
694 674 666 657 642 635 629 617
Retained Earnings
-385 -360 -350 -336 -306 -294 -268 -225
Accumulated Other Comprehensive Income / (Loss)
1.21 1.28 0.46 0.38 0.44 0.36 0.16 -0.49
Noncontrolling Interest
1.13 1.13 1.15 1.15 1.14 1.11 1.10 1.12

Annual Metrics And Ratios for Xometry

This table displays calculated financial ratios and metrics derived from Xometry's official financial filings.

Metric 2024 2023 2022 2021 2020 2019
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Growth Metrics
- - - - - -
Revenue Growth
17.72% 21.65% 74.47% 54.40% 76.26% 0.00%
EBITDA Growth
32.73% 10.39% -20.33% -115.64% 7.14% 0.00%
EBIT Growth
24.21% 5.28% -28.79% -105.20% 2.46% 0.00%
NOPAT Growth
23.69% 4.56% -31.36% -100.87% 4.36% 0.00%
Net Income Growth
25.29% 14.65% -28.77% -97.46% -0.29% 0.00%
EPS Growth
26.95% 16.07% 27.90% 12.41% -9.02% 0.00%
Operating Cash Flow Growth
48.51% 52.25% 8.74% -210.99% 18.71% 0.00%
Free Cash Flow Firm Growth
11.60% 19.35% 77.19% -1,219.27% 0.00% 0.00%
Invested Capital Growth
4.72% 3.38% 7.77% 5,600.13% 0.00% 0.00%
Revenue Q/Q Growth
3.89% 6.94% 8.85% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
5.13% 19.96% -3.09% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
2.87% 16.55% -4.44% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
1.78% 16.75% -6.59% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
1.29% 20.04% -4.71% 0.00% 0.00% 0.00%
EPS Q/Q Growth
16.60% 18.02% -27.27% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
40.29% 34.55% 18.43% -62.21% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
13.65% 13.27% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
-1.65% 0.62% 0.40% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - -
Gross Margin
39.53% 38.47% 38.33% 26.17% 23.54% 18.37%
EBITDA Margin
-7.71% -13.48% -18.31% -26.54% -19.01% -36.08%
Operating Margin
-10.29% -15.88% -20.24% -26.88% -20.66% -38.08%
EBIT Margin
-10.43% -16.20% -20.81% -28.19% -21.21% -38.33%
Profit (Net Income) Margin
-9.24% -14.56% -20.75% -28.11% -21.98% -38.63%
Tax Burden Percent
99.96% 99.48% 100.05% 100.00% 100.00% 100.00%
Interest Burden Percent
88.61% 90.32% 99.66% 99.72% 103.63% 100.78%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-11.32% -15.43% -17.06% -26.51% -765.53% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
-56.98% 76.54% 13.43% -1.91% -717.33% 0.00%
Return on Net Nonoperating Assets (RNNOA)
-4.29% -3.78% -2.77% 0.66% 639.85% 0.00%
Return on Equity (ROE)
-15.60% -19.21% -19.83% -25.85% -125.69% 0.00%
Cash Return on Invested Capital (CROIC)
-15.93% -18.75% -24.53% -219.62% -965.53% 0.00%
Operating Return on Assets (OROA)
-8.20% -10.42% -12.82% -20.81% -33.72% 0.00%
Return on Assets (ROA)
-7.27% -9.36% -12.78% -20.75% -34.94% 0.00%
Return on Common Equity (ROCE)
-15.55% -19.15% -19.78% -17.04% 282.68% 0.00%
Return on Equity Simple (ROE_SIMPLE)
-16.03% -20.49% -21.32% -14.46% 27.94% 0.00%
Net Operating Profit after Tax (NOPAT)
-39 -52 -54 -41 -20 -21
NOPAT Margin
-7.20% -11.11% -14.17% -18.82% -14.46% -26.65%
Net Nonoperating Expense Percent (NNEP)
45.67% -91.97% -30.49% -24.60% -48.20% 0.00%
Return On Investment Capital (ROIC_SIMPLE)
-6.56% -8.41% -8.28% - - -
Cost of Revenue to Revenue
60.47% 61.53% 61.67% 73.83% 76.46% 81.63%
SG&A Expenses to Revenue
11.91% 15.30% 15.29% 16.00% 8.52% 9.99%
R&D to Revenue
7.21% 7.44% 8.14% 8.14% 8.62% 13.26%
Operating Expenses to Revenue
49.82% 54.34% 58.56% 53.05% 44.20% 56.45%
Earnings before Interest and Taxes (EBIT)
-57 -75 -79 -62 -30 -31
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-42 -62 -70 -58 -27 -29
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
6.72 4.95 3.89 5.04 0.00 0.00
Price to Tangible Book Value (P/TBV)
107.72 53.24 19.68 16.71 0.00 0.00
Price to Revenue (P/Rev)
3.88 3.52 3.79 9.80 2.14 3.77
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
6.07 4.83 4.27 6.63 78.44 0.00
Enterprise Value to Revenue (EV/Rev)
3.95 3.54 3.68 9.25 2.96 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
0.90 0.85 0.75 0.00 0.32 0.00
Long-Term Debt to Equity
0.90 0.85 0.75 0.00 0.00 0.00
Financial Leverage
0.08 -0.05 -0.21 -0.35 -0.89 0.00
Leverage Ratio
2.15 2.05 1.55 1.25 1.80 0.00
Compound Leverage Factor
1.90 1.85 1.55 1.24 1.86 0.00
Debt to Total Capital
47.33% 46.03% 42.95% 0.00% 24.15% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 24.15% 0.00%
Long-Term Debt to Total Capital
47.33% 46.03% 42.95% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.19% 0.18% 0.17% 0.24% 246.43% 0.00%
Common Equity to Total Capital
52.48% 53.79% 56.88% 99.76% -170.58% 0.00%
Debt to EBITDA
-6.75 -4.51 -4.01 0.00 -0.59 0.00
Net Debt to EBITDA
-0.95 -0.14 0.63 0.00 1.64 0.00
Long-Term Debt to EBITDA
-6.75 -4.51 -4.01 0.00 0.00 0.00
Debt to NOPAT
-7.22 -5.47 -5.19 0.00 -0.77 0.00
Net Debt to NOPAT
-1.01 -0.17 0.81 0.00 2.16 0.00
Long-Term Debt to NOPAT
-7.22 -5.47 -5.19 0.00 0.00 0.00
Altman Z-Score
3.69 2.73 2.60 16.45 3.84 0.00
Noncontrolling Interest Sharing Ratio
0.35% 0.31% 0.27% 34.06% 324.91% 0.00%
Liquidity Ratios
- - - - - -
Current Ratio
4.38 4.28 6.05 2.87 2.02 0.00
Quick Ratio
4.20 4.07 5.76 2.62 1.94 0.00
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
-55 -63 -78 -340 -26 0.00
Operating Cash Flow to CapEx
-85.38% -163.59% -464.86% -1,095.03% -526.23% -1,068.75%
Free Cash Flow to Firm to Interest Expense
-11.64 -13.08 -17.57 -399.41 -23.69 0.00
Operating Cash Flow to Interest Expense
-3.24 -6.25 -14.16 -80.48 -20.25 -112.55
Operating Cash Flow Less CapEx to Interest Expense
-7.03 -10.06 -17.21 -87.83 -24.09 -123.08
Efficiency Ratios
- - - - - -
Asset Turnover
0.79 0.64 0.62 0.74 1.59 0.00
Accounts Receivable Turnover
7.57 7.76 9.32 9.29 9.70 0.00
Inventory Turnover
97.03 127.98 130.37 74.51 47.13 0.00
Fixed Asset Turnover
13.56 16.94 25.94 26.63 23.13 0.00
Accounts Payable Turnover
8.36 10.13 18.68 17.56 19.17 0.00
Days Sales Outstanding (DSO)
48.19 47.01 39.14 39.29 37.62 0.00
Days Inventory Outstanding (DIO)
3.76 2.85 2.80 4.90 7.74 0.00
Days Payable Outstanding (DPO)
43.65 36.04 19.54 20.78 19.04 0.00
Cash Conversion Cycle (CCC)
8.31 13.82 22.40 23.40 26.32 0.00
Capital & Investment Metrics
- - - - - -
Invested Capital
355 339 328 305 5.34 0.00
Invested Capital Turnover
1.57 1.39 1.20 1.41 52.93 0.00
Increase / (Decrease) in Invested Capital
16 11 24 299 5.34 0.00
Enterprise Value (EV)
2,155 1,640 1,400 2,020 419 0.00
Market Capitalization
2,114 1,630 1,443 2,139 303 303
Book Value per Share
$6.34 $7.25 $8.28 $10.17 ($14.85) $0.00
Tangible Book Value per Share
$0.40 $0.67 $1.64 $3.07 ($15.18) $0.00
Total Capital
599 612 652 425 65 0.00
Total Debt
284 282 280 0.00 16 0.00
Total Long-Term Debt
284 282 280 0.00 0.00 0.00
Net Debt
40 8.88 -44 -121 -44 0.00
Capital Expenditures (CapEx)
18 18 13 6.26 4.19 2.54
Debt-free, Cash-free Net Working Capital (DFCFNWC)
13 4.26 3.79 -10 -4.85 0.00
Debt-free Net Working Capital (DFNWC)
253 273 323 106 55 0.00
Net Working Capital (NWC)
253 273 323 106 39 0.00
Net Nonoperating Expense (NNE)
11 16 25 20 11 9.61
Net Nonoperating Obligations (NNO)
40 8.88 -44 -121 -44 0.00
Total Depreciation and Amortization (D&A)
15 13 9.54 3.60 3.12 1.81
Debt-free, Cash-free Net Working Capital to Revenue
2.37% 0.92% 0.99% -4.73% -3.43% 0.00%
Debt-free Net Working Capital to Revenue
46.33% 58.92% 84.85% 48.73% 38.91% 0.00%
Net Working Capital to Revenue
46.33% 58.92% 84.85% 48.73% 27.77% 0.00%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
($2.06) ($2.82) ($1.61) ($2.33) $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
98.17M 95.83M 47.16M 44.16M 0.00 0.00
Adjusted Diluted Earnings per Share
($2.06) ($2.82) ($1.61) ($2.33) $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
98.17M 95.83M 47.16M 44.16M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 ($2.33) $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
50.30M 48.58M 45.07M 26.32M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
-39 -51 -53 -41 -19 -20
Normalized NOPAT Margin
-7.19% -11.05% -14.02% -18.82% -13.67% -25.15%
Pre Tax Income Margin
-9.24% -14.63% -20.74% -28.11% -21.98% -38.63%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
-11.98 -15.70 -17.94 -72.24 -27.54 -127.61
NOPAT to Interest Expense
-8.27 -10.77 -12.21 -48.22 -18.78 -88.73
EBIT Less CapEx to Interest Expense
-15.77 -19.51 -20.99 -79.59 -31.39 -138.14
NOPAT Less CapEx to Interest Expense
-12.06 -14.58 -15.26 -55.57 -22.63 -99.26
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% -28.31% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% -5.99% -28.31% 0.00%

Quarterly Metrics And Ratios for Xometry

This table displays calculated financial ratios and metrics derived from Xometry's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
23.05% 15.92% 19.15% 19.45% 16.49% 30.67% 14.83% 16.10% 25.88% 46.15% 82.58%
EBITDA Growth
20.97% 23.58% 64.18% 9.86% 12.61% 61.81% -75.66% 3.79% 5.99% -9.04% 7.88%
EBIT Growth
10.81% 13.02% 13.55% 45.78% 7.72% 53.60% 10.94% -78.01% 0.73% -13.80% -2.92%
NOPAT Growth
13.81% 8.11% 13.00% 45.50% 9.75% 54.13% 13.17% -79.82% -4.40% -21.11% -6.56%
Net Income Growth
9.20% 6.23% 15.08% 48.40% 9.48% 61.57% 20.15% -60.49% 8.26% -14.86% -2.24%
EPS Growth
11.76% 25.00% 16.00% 49.09% 10.53% 27.43% 21.88% -57.14% 11.63% -46.75% 3.03%
Operating Cash Flow Growth
68.54% 802.09% 39.19% -47.94% 28.69% 92.42% 47.18% 38.09% 32.17% 45.31% 32.69%
Free Cash Flow Firm Growth
-54.69% -21.26% -64.18% 1.42% 60.70% 53.57% 93.91% 89.76% 87.70% 0.00% -1,116.92%
Invested Capital Growth
4.00% 4.72% 7.13% 6.53% 1.00% 3.38% 3.15% 4.15% 8.43% 7.77% 1,892.65%
Revenue Q/Q Growth
1.63% 4.83% 6.87% 8.07% -4.26% 7.75% 7.13% 5.39% 7.41% -5.32% 8.32%
EBITDA Q/Q Growth
-57.07% 10.77% 30.10% 19.33% -51.87% 58.18% -75.91% 21.79% 33.62% -92.35% 3.65%
EBIT Q/Q Growth
-45.08% 5.95% 23.17% 14.92% -41.49% 6.52% 51.82% -44.81% 28.85% -79.42% 3.70%
NOPAT Q/Q Growth
-33.58% -0.36% 24.91% 14.38% -42.41% 4.99% 52.96% -41.77% 27.62% -79.87% 2.58%
Net Income Q/Q Growth
-52.34% 2.97% 25.58% 17.47% -57.34% 12.13% 54.78% -44.79% 33.20% -82.55% 9.11%
EPS Q/Q Growth
75.61% -485.71% 25.00% 17.65% 79.27% -556.00% 54.55% -44.74% 83.19% -606.25% 8.57%
Operating Cash Flow Q/Q Growth
-140.63% 350.00% 60.07% 22.44% -806.80% 78.35% 2.86% 62.61% 3.57% -50.83% -13.86%
Free Cash Flow Firm Q/Q Growth
-2.15% 24.93% 1.07% -103.92% 19.92% -1.63% 40.60% 18.71% 5.38% 86.68% 0.11%
Invested Capital Q/Q Growth
1.22% -1.65% 1.87% 2.54% 1.93% 0.62% 1.30% -2.78% 4.33% 0.40% 2.28%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
37.31% 39.73% 39.40% 39.88% 39.04% 38.30% 38.89% 39.24% 37.38% 35.14% 39.49%
EBITDA Margin
-7.66% -4.95% -5.82% -8.90% -11.92% -7.52% -19.36% -11.79% -15.89% -25.71% -12.66%
Operating Margin
-10.19% -7.76% -8.10% -11.53% -14.55% -9.79% -11.10% -25.27% -18.79% -27.88% -14.68%
EBIT Margin
-10.78% -7.55% -8.42% -11.71% -14.87% -10.06% -11.60% -25.79% -18.77% -28.34% -14.95%
Profit (Net Income) Margin
-9.99% -6.66% -7.20% -10.34% -13.53% -8.24% -10.10% -23.93% -17.42% -28.00% -14.52%
Tax Burden Percent
100.00% 99.59% 100.30% 99.93% 100.00% 94.95% 101.17% 99.75% 100.75% 102.21% 100.00%
Interest Burden Percent
92.66% 88.60% 85.27% 88.35% 91.01% 86.20% 86.06% 93.00% 92.09% 96.67% 97.11%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-11.61% -8.53% -8.53% -11.80% -14.23% -9.51% -10.14% -22.66% -16.09% -23.50% -20.94%
ROIC Less NNEP Spread (ROIC-NNEP)
-23.41% -16.06% -18.09% -33.18% -204.15% 0.72% -1.70% -7.54% -8.23% -13.38% -18.69%
Return on Net Nonoperating Assets (RNNOA)
-2.70% -1.21% -1.25% -1.41% -1.29% -0.04% 0.15% 0.93% 1.22% 2.76% 9.95%
Return on Equity (ROE)
-14.31% -9.74% -9.78% -13.21% -15.52% -9.55% -9.98% -21.73% -14.87% -20.73% -11.00%
Cash Return on Invested Capital (CROIC)
-14.57% -15.93% -18.35% -18.31% -15.56% -18.75% -21.73% -23.46% -24.67% -24.53% 0.00%
Operating Return on Assets (OROA)
-8.95% -5.94% -6.41% -8.48% -10.09% -6.47% -6.91% -14.70% -10.17% -17.46% -9.31%
Return on Assets (ROA)
-8.29% -5.24% -5.48% -7.49% -9.18% -5.29% -6.02% -13.64% -9.44% -17.25% -9.04%
Return on Common Equity (ROCE)
-14.25% -9.70% -9.75% -13.16% -15.47% -9.52% -9.95% -21.67% -14.83% -20.68% -10.98%
Return on Equity Simple (ROE_SIMPLE)
-15.77% 0.00% -16.20% -16.74% -20.51% 0.00% -25.13% -25.60% -21.42% 0.00% -19.27%
Net Operating Profit after Tax (NOPAT)
-11 -8.07 -8.04 -11 -12 -8.78 -9.24 -20 -14 -19 -11
NOPAT Margin
-7.14% -5.43% -5.67% -8.07% -10.19% -6.85% -7.77% -17.69% -13.15% -19.51% -10.27%
Net Nonoperating Expense Percent (NNEP)
11.81% 7.53% 9.56% 21.39% 189.92% -10.23% -8.44% -15.12% -7.86% -10.12% -2.25%
Return On Investment Capital (ROIC_SIMPLE)
-1.81% -1.35% - - - -1.43% - - - -2.94% -
Cost of Revenue to Revenue
62.69% 60.27% 60.60% 60.12% 60.96% 61.70% 61.11% 60.76% 62.62% 64.86% 60.51%
SG&A Expenses to Revenue
11.28% 11.77% 11.33% 12.43% 12.16% 11.27% 12.56% 23.05% 15.15% 15.40% 14.60%
R&D to Revenue
7.40% 6.98% 6.59% 7.56% 7.82% 6.94% 7.17% 8.04% 7.71% 8.48% 7.35%
Operating Expenses to Revenue
47.51% 47.49% 47.50% 51.41% 53.60% 48.09% 49.99% 64.51% 56.16% 63.01% 54.17%
Earnings before Interest and Taxes (EBIT)
-16 -11 -12 -16 -18 -13 -14 -29 -20 -28 -15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-12 -7.36 -8.25 -12 -15 -9.63 -23 -13 -17 -25 -13
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.04 6.72 2.87 1.69 2.56 4.95 2.29 2.80 1.87 3.89 6.46
Price to Tangible Book Value (P/TBV)
80.11 107.72 47.07 27.93 36.04 53.24 21.25 23.46 11.29 19.68 27.65
Price to Revenue (P/Rev)
2.18 3.88 1.72 1.06 1.71 3.52 1.77 2.29 1.68 3.79 7.24
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
3.62 6.07 2.63 1.61 2.45 4.83 2.28 2.85 1.92 4.27 7.55
Enterprise Value to Revenue (EV/Rev)
2.27 3.95 1.81 1.14 1.76 3.54 1.78 2.27 1.63 3.68 7.05
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.91 0.90 0.90 0.89 0.88 0.85 0.84 0.82 0.77 0.75 0.71
Long-Term Debt to Equity
0.91 0.90 0.90 0.89 0.88 0.85 0.84 0.82 0.77 0.75 0.71
Financial Leverage
0.12 0.08 0.07 0.04 0.01 -0.05 -0.09 -0.12 -0.15 -0.21 -0.53
Leverage Ratio
2.19 2.15 2.11 2.10 2.07 2.05 1.99 1.97 1.92 1.55 1.53
Compound Leverage Factor
2.02 1.90 1.80 1.86 1.89 1.77 1.72 1.83 1.77 1.50 1.49
Debt to Total Capital
47.74% 47.33% 47.23% 47.14% 46.74% 46.03% 45.50% 45.06% 43.62% 42.95% 41.56%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
47.74% 47.33% 47.23% 47.14% 46.74% 46.03% 45.50% 45.06% 43.62% 42.95% 41.56%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.19% 0.19% 0.19% 0.19% 0.19% 0.18% 0.18% 0.18% 0.17% 0.17% 0.17%
Common Equity to Total Capital
52.07% 52.48% 52.58% 52.67% 53.07% 53.79% 54.31% 54.77% 56.21% 56.88% 58.28%
Debt to EBITDA
-7.29 -6.75 -6.39 -4.78 -4.67 -4.51 -3.60 -4.12 -4.08 -4.01 -4.13
Net Debt to EBITDA
-1.25 -0.95 -1.01 -0.64 -0.40 -0.14 0.00 0.14 0.29 0.63 0.98
Long-Term Debt to EBITDA
-7.29 -6.75 -6.39 -4.78 -4.67 -4.51 -3.60 -4.12 -4.08 -4.01 -4.13
Debt to NOPAT
-7.56 -7.22 -7.08 -6.86 -5.63 -5.47 -4.55 -4.44 -5.14 -5.19 -5.52
Net Debt to NOPAT
-1.29 -1.01 -1.12 -0.91 -0.48 -0.17 -0.01 0.15 0.37 0.81 1.30
Long-Term Debt to NOPAT
-7.56 -7.22 -7.08 -6.86 -5.63 -5.47 -4.55 -4.44 -5.14 -5.19 -5.52
Altman Z-Score
2.38 3.91 1.92 1.28 1.71 3.02 1.71 1.94 1.58 2.83 4.73
Noncontrolling Interest Sharing Ratio
0.36% 0.35% 0.35% 0.34% 0.33% 0.31% 0.31% 0.30% 0.28% 0.27% 0.15%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.74 4.38 4.59 4.64 4.34 4.28 5.27 5.28 5.75 6.05 6.30
Quick Ratio
3.54 4.20 4.41 4.42 4.10 4.07 5.03 4.98 5.38 5.76 6.03
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-25 -24 -32 -32 -16 -20 -20 -33 -40 -43 -321
Operating Cash Flow to CapEx
-67.12% 200.24% -75.55% -210.48% -269.93% -20.15% -167.35% -142.87% -415.22% -424.71% -271.19%
Free Cash Flow to Firm to Interest Expense
-20.71 -20.28 -27.04 -27.31 -13.38 -16.72 -16.22 -27.59 -33.79 -34.34 -268.97
Operating Cash Flow to Interest Expense
-3.11 7.65 -3.06 -7.66 -9.87 -1.09 -4.96 -5.16 -13.74 -13.70 -9.48
Operating Cash Flow Less CapEx to Interest Expense
-7.74 3.83 -7.11 -11.30 -13.52 -6.50 -7.92 -8.77 -17.04 -16.92 -12.97
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.83 0.79 0.76 0.72 0.68 0.64 0.60 0.57 0.54 0.62 0.62
Accounts Receivable Turnover
7.41 7.57 7.37 7.81 7.91 7.76 7.55 8.22 8.88 9.32 9.20
Inventory Turnover
101.06 97.03 132.85 145.48 135.66 127.98 77.71 169.40 137.30 130.37 61.62
Fixed Asset Turnover
13.53 13.56 15.44 15.79 16.25 16.94 20.64 22.33 24.23 25.94 28.09
Accounts Payable Turnover
10.89 8.36 32.44 26.82 22.35 10.13 21.24 19.40 22.49 18.68 25.18
Days Sales Outstanding (DSO)
49.25 48.19 49.53 46.76 46.14 47.01 48.38 44.38 41.11 39.14 39.66
Days Inventory Outstanding (DIO)
3.61 3.76 2.75 2.51 2.69 2.85 4.70 2.15 2.66 2.80 5.92
Days Payable Outstanding (DPO)
33.50 43.65 11.25 13.61 16.33 36.04 17.19 18.81 16.23 19.54 14.49
Cash Conversion Cycle (CCC)
19.36 8.31 41.02 35.66 32.49 13.82 35.88 27.73 27.54 22.40 31.09
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
360 355 361 355 346 339 337 333 342 328 327
Invested Capital Turnover
1.63 1.57 1.50 1.46 1.40 1.39 1.30 1.28 1.22 1.20 2.04
Increase / (Decrease) in Invested Capital
14 16 24 22 3.41 11 10 13 27 24 311
Enterprise Value (EV)
1,303 2,155 952 572 846 1,640 771 948 656 1,400 2,467
Market Capitalization
1,254 2,114 906 533 820 1,630 769 957 675 1,443 2,532
Book Value per Share
$6.16 $6.34 $6.39 $6.85 $6.60 $7.25 $7.41 $7.56 $8.02 $8.28 $8.79
Tangible Book Value per Share
$0.31 $0.40 $0.39 $0.41 $0.47 $0.67 $0.80 $0.90 $1.33 $1.64 $2.05
Total Capital
595 599 600 600 604 612 618 623 643 652 672
Total Debt
284 284 283 283 282 282 281 281 280 280 279
Total Long-Term Debt
284 284 283 283 282 282 281 281 280 280 279
Net Debt
49 40 45 38 24 8.88 0.33 -9.58 -20 -44 -66
Capital Expenditures (CapEx)
5.50 4.54 4.81 4.32 4.35 6.42 3.57 4.31 3.96 4.02 4.17
Debt-free, Cash-free Net Working Capital (DFCFNWC)
14 13 21 16 8.84 4.26 13 9.63 12 3.79 3.50
Debt-free Net Working Capital (DFNWC)
245 253 255 257 263 273 289 296 308 323 345
Net Working Capital (NWC)
245 253 255 257 263 273 289 296 308 323 345
Net Nonoperating Expense (NNE)
4.30 1.83 2.16 3.00 4.10 1.78 2.77 6.92 4.49 8.32 4.40
Net Nonoperating Obligations (NNO)
49 40 45 38 24 8.88 0.33 -9.58 -20 -44 -66
Total Depreciation and Amortization (D&A)
4.71 3.86 3.68 3.72 3.62 3.26 -9.24 16 3.03 2.57 2.38
Debt-free, Cash-free Net Working Capital to Revenue
2.41% 2.37% 3.96% 3.18% 1.84% 0.92% 2.93% 2.30% 2.94% 0.99% 1.00%
Debt-free Net Working Capital to Revenue
42.73% 46.33% 48.52% 51.14% 54.63% 58.92% 66.80% 70.76% 76.51% 84.85% 98.50%
Net Working Capital to Revenue
42.73% 46.33% 48.52% 51.14% 54.63% 58.92% 66.80% 70.76% 76.51% 84.85% 98.50%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.30) ($1.23) ($0.21) ($0.28) ($0.34) ($1.64) ($0.25) $0.00 ($0.38) ($2.26) ($0.32)
Adjusted Weighted Average Basic Shares Outstanding
50.34M 98.17M 49.28M 48.84M 48.58M 95.83M 47.99M 47.87M 47.70M 94.32M 47.30M
Adjusted Diluted Earnings per Share
($0.30) ($1.23) ($0.21) ($0.28) ($0.34) ($1.64) ($0.25) $0.00 ($0.38) ($2.26) ($0.32)
Adjusted Weighted Average Diluted Shares Outstanding
50.34M 98.17M 49.28M 48.84M 48.58M 95.83M 47.99M 47.87M 47.70M 94.32M 47.30M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
50.68M 50.30M 49.56M 49.30M 46.12M 48.58M 45.39M 45.29M 45.17M 45.07M 44.76M
Normalized Net Operating Profit after Tax (NOPAT)
-11 -8.01 -8.04 -11 -12 -8.78 -9.13 -19 -14 -19 -10
Normalized NOPAT Margin
-7.14% -5.39% -5.67% -8.07% -10.19% -6.85% -7.68% -17.55% -13.13% -19.24% -10.05%
Pre Tax Income Margin
-9.99% -6.69% -7.18% -10.34% -13.53% -8.67% -9.98% -23.99% -17.29% -27.39% -14.52%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-13.70 -9.44 -10.05 -13.07 -15.34 -10.85 -11.45 -24.00 -16.50 -22.30 -12.97
NOPAT to Interest Expense
-9.07 -6.79 -6.77 -9.01 -10.51 -7.39 -7.67 -16.46 -11.56 -15.36 -8.91
EBIT Less CapEx to Interest Expense
-18.32 -13.26 -14.10 -16.71 -19.00 -16.26 -14.41 -27.61 -19.81 -25.53 -16.47
NOPAT Less CapEx to Interest Expense
-13.70 -10.61 -10.82 -12.65 -14.17 -12.79 -10.63 -20.07 -14.87 -18.58 -12.40
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Xometry's Financials

When does Xometry's financial year end?

According to the most recent income statement we have on file, Xometry's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Xometry's net income changed over the last 5 years?

Xometry's net income appears to be on an upward trend, with a most recent value of -$50.40 million in 2024, rising from -$30.99 million in 2019. The previous period was -$67.47 million in 2023. Find out what analysts predict for Xometry in the coming months.

What is Xometry's operating income?
Xometry's total operating income in 2024 was -$56.15 million, based on the following breakdown:
  • Total Gross Profit: $215.62 million
  • Total Operating Expenses: $271.77 million
How has Xometry revenue changed over the last 5 years?

Over the last 5 years, Xometry's total revenue changed from $80.23 million in 2019 to $545.53 million in 2024, a change of 580.0%.

How much debt does Xometry have?

Xometry's total liabilities were at $364.53 million at the end of 2024, a 3.3% decrease from 2023, and a 822.9% increase since 2020.

How much cash does Xometry have?

In the past 4 years, Xometry's cash and equivalents has ranged from $22.23 million in 2024 to $86.26 million in 2021, and is currently $22.23 million as of their latest financial filing in 2024.

How has Xometry's book value per share changed over the last 5 years?

Over the last 5 years, Xometry's book value per share changed from 0.00 in 2019 to 6.34 in 2024, a change of 634.4%.



This page (NASDAQ:XMTR) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners